Germany's annual congress of pharmaceutical medicine will focus on the state of the medical research landscape in Germany. Updates will be provide on the implementation of the Medical Research Act in clinical research and on health technology assessment (HTA). Speakers will also explore the applications of artificial intelligence in clinical studies.
The congress is organised by the German society of pharmaceutical medicine (DGPharmed).
Berlin
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.